Stocks In Focus For Wednesday 05/13/15 – VTEQ ADMD PMCB


Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Hi Everyone & Welcome New Subscribers,

TPIV (TapImmune Inc.) continued it’s ascent today, adding another 2.95% to it’s already impressive rally, with another record volume performance. It’s possible the stock has reached a short term top, but if it dips back below .25 it could be a prime opportunity.

VTEQ (VeriTeQ Corp.) was the talk of the town around the OTC today, closing up 300% at .0012 on the day with more than 758 million shares exchanging hands between .0003-.0014; an impressive day to say the least. With a strong open, and break of today’s high, VTEQ could continue higher towards .002 or more. Keep the stock on top of your watch list.

ADMD (Advanced Medical Isotope Corp.) continued higher to another new high of .0061 today, closing just below that level at .006 up 20.00%, as the stock maintains it’s upward trend that started just before the year began. With more volume, we would expect another breakout higher tomorrow. Keep the stock on your watch list tomorrow.

PMCB (PharmaCyte Biotech, Inc.) has been holding the .15 range as support ever since falling from it’s high of .26 a few weeks ago, and has started to form a channel between .15-.17 that it might soon breakout from. Keep the stock on your watch list tomorrow.

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!


The Penny Stock Experts Team At 

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using or joining the email list. reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Your continued use of the website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS. 

Neither nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit does not accept free-trading shares as a form of payment.